Yap1 AS A THERAPEUTIC TARGET IN FIBROLAMELLAR CARCINOMA

被引：0
|
作者：
Oh, Seh-Hoon [1 ]
Jewell, Mark [2 ]
Premont, Richard T. [3 ]
Gibson, Jason [4 ]
Glover, Wayne [5 ]
Gregory, Simon G. [4 ]
Hsu, David [5 ]
Guy, Cynthia D. [6 ]
Diehl, Anna Mae [7 ]
机构：
[1] Duke Univ, Med, Durham, NC 27706 USA
[2] Duke Univ, Dept Med, Durham, NC 27706 USA
[3] Duke Univ, Durham, NC 27706 USA
[4] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27706 USA
[5] Duke Univ, Duke Canc Inst, Durham, NC 27706 USA
[6] Duke Univ, Pathol, Durham, NC 27706 USA
[7] Duke Univ, Div Gastroenterol, Dept Med, Durham, NC USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1474
引用
收藏
页码：888A / 889A
页数：2
相关论文
共 50 条
  • [1] Yap1 As a Therapeutic Target in Fibrolamellar Carcinoma
    Jewell, Mark
    Premont, Richard T.
    Gibson, Jason
    Glover, Wayne
    Dinh, Timothy A.
    Wauthier, Eliane L.
    Reid, Lola M.
    Gregory, Simon G.
    Sethupathy, Praveen
    Hsu, David S.
    Diehl, Anna Mae
    HEPATOLOGY, 2018, 68 : 1243A - 1243A
  • [2] YAP1 Expression in Lichen Planus and Squamous Cell Carcinoma: Role in Disease Pathogenesis and Potential Therapeutic Target
    Neinaa, Yomna Mazid El-Hamd
    Mohamed, Dareen Abd El-Aziz
    Ali, Shereen Abd El-Moula
    Gaballah, Hanaa Hibishy
    El-Tatawy, Rania Ahmed
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2022, 44 (05) : 348 - 354
  • [3] Evaluating PRKACA as a therapeutic target for Fibrolamellar Carcinoma
    Schalm, Stefanie S.
    O'Hearn, Erin
    Wilson, Kevin
    LaBranche, Timothy
    Silva, Grace
    DiPietro, Lucian
    Bifulco, Neil
    Woessner, Richard
    Stransky, Nicolas
    Sappal, Darshan
    Shutes, Adam
    Campbell, Robert
    Lobbardi, Riadh
    Palmer, Michael
    Kim, Joseph
    Miller, Stephen
    Dorsch, Marion
    Lengauer, Christoph
    Guzi, Timothy
    Kadambi, Vivek
    Garner, Andrew
    Hoeflich, Klaus P.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [4] YAP1 expression in Merkel Cell Carcinoma
    Sykaras, A.
    Kyriakopoulos, G.
    Kazamias, G.
    Stamou, C.
    Pantelakos, S.
    Dolkiras, P.
    Kouvidou, C.
    VIRCHOWS ARCHIV, 2019, 475 : S29 - S29
  • [5] Oncogenic HIPPO-YAP1: in vivo target validation of YAP1 in malignant mesothelioma
    Calvet, Loreley
    Dos Santos, Odette
    Jean-Baptiste, Veronique
    Spanakis, Emmanuel
    Ruffin, Yvette
    Sanchez, Isabelle
    Mestadier, Jessica
    Soubigou, Stephane
    Feteanu, Sylvie
    Picard, Pascale
    Boumaya, Chagri
    Pollard, Jack
    Dib, Colette
    Sidhu, Sukhvinder
    Debussche, Laurent
    Valtingojer, Iris
    CANCER RESEARCH, 2020, 80 (16)
  • [6] YAP1 is essential for tumor growth and is a potential therapeutic target for EGFR-dependent lung adenocarcinomas
    Lee, Ting-Fang
    Tseng, Yu-Chi
    Chang, Wei-Chin
    Chen, Yi-Chen
    Kao, Yu-Rung
    Chou, Teh-Ying
    Ho, Chao-Chi
    Wu, Cheng-Wen
    ONCOTARGET, 2017, 8 (52): : 89539 - 89551
  • [7] Therapeutic inhibition of YAP1 expression by next-generation antisense oligonucleotides leads to antitumor activity in head and neck squamous cell carcinoma with YAP1 activation.
    Luo, Xiaolin
    Kim, Youngsoo
    Schmidt, Joanna
    Li, Jian
    Fleming, Rachel
    Malik, Shivani
    Klein, Stephanie
    MacLeod, A. Robert
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 46 - 47
  • [8] Targeting the Hippo/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review)
    Li, Shenghao
    Hao, Liyuan
    Li, Na
    Hu, Xiaoyu
    Yan, Huimin
    Dai, Erhei
    Shi, Xinli
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2024, 65 (03)
  • [9] YAP1 drives immune suppression in urothelial carcinoma of bladder
    Sadhukhan, Pritam
    Feng, Mingxiao
    Illingworth, Emily
    Sloma, Ido
    Ugurlu, M. Talha
    Sille, Fenna
    Choi, Woonyoung
    McConkey, David J.
    Hoque, Mohammad
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [10] Targeting YAP1 as a biomarker of resistance and therapeutic strategy in melanoma immunotherapy
    Kovacs, S. A.
    Kovacs, T.
    Paal, A.
    Hegedus, Z.
    Varga, Z.
    Fekete, J. T.
    Gyorffy, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S223 - S224
12345